RELATION OF POLISH HTA RECOMMENDATIONS AND DECISIONS ISSUED BY SELECTED NATIONAL HTA AGENCIES.
Author(s)
Kawalec P, Malinowski K
Jagiellonian University Medical College Institute of Public Health, Kraków, Poland
OBJECTIVES: The aim of this research was to assess the agreement between recommendations issued by the Polish HTA Agency (AOTMiT) and recommendations published by other national HTA agencies chosen for reference by the Polish HTA Agency. METHODS: All recommendations produced by the AOTMiT for years 2013–2015 were collected and scanned for references to corresponding recommendations issued by selected national HTA agencies. The agreement in type of recommendation between the AOTMiT and other HTA agencies was measured using Kappa coefficient. Odds for positive recommendations of the AOTMiT assuming positive recommendations of other national HTA agencies were estimated using logistic regression. RESULTS: In total 265 recommendations by the AOTMiT were analysed of which 174 were positive (and suggest reimbursement). Six national agencies were considered (NICE, CADTH, SMC, PBAC, HAS, AWMSG) of which significant agreement was observed only for: CADTH (kappa of 0.2393 (95%CI: 0.0111 - 0.4675)) and PBAC (kappa of 0.2319 (95%CI: 0.0615 - 0.4022)). Significant odds for positive recommendations by the AOTMiT for drugs with positive recommendation by other agency were revealed just for the same national HTA agencies: CADTH (3.09 (95%CI: 1.06 - 9.45)) and PBAC (3.55 (95%CI: 1.46 - 8.89)). CONCLUSIONS: Agreement between AOTMiT and other agencies was significant only for CADTH and PBAC. The regression analysis showed that in all cases positive recommendation by the national HTA agency outside Poland was associated with the grater odds for the positive recommendation by the AOTMiT, however only in case of CADTH and PBAC the statistical significance was revealed.
Conference/Value in Health Info
2017-05, ISPOR 2017, Boston, MA, USA
Value in Health, Vol. 20, No. 5 (May 2017)
Code
PHP164
Topic
Health Policy & Regulatory, Health Technology Assessment
Topic Subcategory
Decision & Deliberative Processes, Reimbursement & Access Policy
Disease
Multiple Diseases